Puma Biotechnology Inc (PBYI) financial statements (2022 and earlier)

Company profile

Business Address 10880 WILSHIRE BLVD.
LOS ANGELES, CA 90024
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:709311216582229216
Cash and cash equivalents6385601088219432
Short-term investments1985257 35184
Other undisclosed cash, cash equivalents, and short-term investments(12)   0(0) 
Restricted cash and investments999    
Receivables3326292110  
Inventory, net of allowances, customer advances and progress billings73332  
Inventory73332  
Prepaid expense91113    
Deferred rent asset 00    
Other current assets0302   
Other undisclosed current assets12  121378
Total current assets:140146166203106236224
Noncurrent Assets
Operating lease, right-of-use asset141619
Property, plant and equipment2234452
Intangible assets, net (including goodwill)6674404448  
Intangible assets, net (excluding goodwill)6674404448  
Prepaid expense1      
Restricted cash and investments3344444
Other undisclosed noncurrent assets12232710
Total noncurrent assets:87986956591616
TOTAL ASSETS:227244235259166253240
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities104738867583732
Accounts payable11121921282018
Accrued liabilities93616946311715
Debt 143    
Other undisclosed current liabilities627     
Total current liabilities:1101149167583732
Noncurrent Liabilities
Long-term debt and lease obligation11310423    
Long-term debt, excluding current maturities9784     
Operating lease, liability162023
Liabilities, other than long-term debt00 6561
Deferred revenue and credits561
Accounts payable and accrued liabilities00     
Deferred rent credit   6
Other undisclosed noncurrent liabilities63210415248  
Total noncurrent liabilities:1191361271585461
Total liabilities:2292502172251124334
Stockholders' equity
Stockholders' equity attributable to parent(2)(6)173453210206
Common stock0000000
Additional paid in capital1,3641,3321,2951,2361,1421,006727
Accumulated other comprehensive income (loss)(0) 0(0) (0)(0)
Accumulated deficit(1,367)(1,338)(1,278)(1,202)(1,088)(797)(521)
Receivable from shareholders or affiliates for issuance of capital stock    (0)  
Total stockholders' equity:(2)(6)173453210206
TOTAL LIABILITIES AND EQUITY:227244235259166253240

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues25322527225128  
Revenue, net28(3)(0)
Cost of revenue
(Cost of Goods and Services Sold)
(64)  (35)(6)  
Gross profit:18922527221622  
Operating expenses(188)(256)(311)(346)(320)(277)(240)
Other undisclosed operating income   35630
Operating income (loss):1(30)(39)(95)(292)(277)(240)
Nonoperating income (expense)(30)(29)(36)(19)011
Investment income, nonoperating0032111
Other nonoperating income (expense)000(1)(0)(0)0
Interest and debt expense(8)(14)(8)(0)(1)  
Loss from continuing operations before equity method investments, income taxes:(37)(74)(84)(114)(293)(276)(239)
Other undisclosed income from continuing operations before income taxes814     
Loss from continuing operations before income taxes:(29)(60)(84)(114)(293)(276)(239)
Income tax expense(0)(0)(0)(0)   
Loss before gain (loss) on sale of properties:(29)(60)(84)(114)(293)(276)(239)
Other undisclosed net income  80   
Net loss:(29)(60)(76)(114)(293)(276)(239)
Other undisclosed net income attributable to parent    1  
Net loss available to common stockholders, diluted:(29)(60)(76)(114)(292)(276)(239)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(29)(60)(76)(114)(293)(276)(239)
Comprehensive loss:(29)(60)(76)(114)(293)(276)(239)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0(0)10(0)
Comprehensive loss, net of tax, attributable to parent:(29)(60)(76)(114)(292)(276)(239)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: